⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRDL News
Cardiol Therapeutics Inc. Class A Common Shares
Cordial Expands Its AI Capabilities to Help Brands Close the Intent Divide
prnewswire.com
CRDL
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
newsfilecorp.com
CRDL
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
newsfilecorp.com
CRDL
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
newsfilecorp.com
CRDL